Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

PURPOSE: The purpose of this study is to define which visual acuity (VA) measurements are the best indicators of high-quality care for patients receiving intravitreal ranibizumab for neovascular age-related macular degeneration (nAMD). METHODS: Analysis of prospectively collected data recorded withi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ross, A H, Donachie, P H J, Sallam, A, Stratton, I M, Mohamed, Q, Scanlon, P H, Kirkpatrick, J N, Johnston, R L
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2013
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3545383/
https://ncbi.nlm.nih.gov/pubmed/23174752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2012.225
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires